Therapeutic efficacy of single-dose iso-[211At]SAGMBanti- HER2 sdAb in mice with subcutaneous HER2- expressing breast carcinoma xenografts

Category Primary study
JournalJournal of Nuclear Medicine
Year 2021
This article has no abstract
Epistemonikos ID: 5e33f8d6e05a95d46fc160bb4bb789a9d818fcf7
First added on: Feb 13, 2025